Aβ42‐driven cerebral amyloidosis in transgenic mice reveals early and robust pathology
Top Cited Papers
Open Access
- 11 August 2006
- journal article
- research article
- Published by Springer Nature in EMBO Reports
- Vol. 7 (9) , 940-946
- https://doi.org/10.1038/sj.embor.7400784
Abstract
We have generated a novel transgenic mouse model on a C57BL/6J genetic background that coexpresses KM670/671NL mutated amyloid precursor protein and L166P mutated presenilin 1 under the control of a neuron‐specific Thy1 promoter element (APPPS1 mice). Cerebral amyloidosis starts at 6–8 weeks and the ratio of human amyloid (A)β42 to Aβ40 is 1.5 and 5 in pre‐depositing and amyloid‐depositing mice, respectively. Consistent with this ratio, extensive congophilic parenchymal amyloid but minimal amyloid angiopathy is observed. Amyloid‐associated pathologies include dystrophic synaptic boutons, hyperphosphorylated tau‐positive neuritic structures and robust gliosis, with neocortical microglia number increasing threefold from 1 to 8 months of age. Global neocortical neuron loss is not apparent up to 8 months of age, but local neuron loss in the dentate gyrus is observed. Because of the early onset of amyloid lesions, the defined genetic background of the model and the facile breeding characteristics, APPPS1 mice are well suited for studying therapeutic strategies and the pathomechanism of amyloidosis by cross‐breeding to other genetically engineered mouse models.Keywords
This publication has 31 references indexed in Scilit:
- Mean age-of-onset of familial alzheimer disease caused by presenilin mutations correlates with both increased Aβ42 and decreased Aβ40Human Mutation, 2006
- Lack of the metabotropic glutamate receptor subtype 7 selectively impairs short-term working memory but not long-term memoryBehavioural Brain Research, 2004
- Inflammation occurs early during the Aβ deposition process in TgCRND8 miceNeurobiology of Aging, 2004
- Genetic background regulates -amyloid precursor protein processing and -amyloid deposition in the mouseHuman Molecular Genetics, 2003
- Alzheimer's Disease: Molecular Understanding Predicts Amyloid-Based TherapeuticsAnnual Review of Pharmacology and Toxicology, 2003
- Neurotoxic effects of thioflavin S-positive amyloid deposits in transgenic mice and Alzheimer's diseaseProceedings of the National Academy of Sciences, 2002
- Presenilin-1 mutations of leucine 166 equally affect the generation of the Notch and APP intracellular domains independent of their effect on Aβ 42 productionProceedings of the National Academy of Sciences, 2002
- Amyloid-Associated Neuron Loss and Gliogenesis in the Neocortex of Amyloid Precursor Protein Transgenic MiceJournal of Neuroscience, 2002
- Inflammatory Responses to Amyloidosis in a Transgenic Mouse Model of Alzheimer’s DiseaseThe American Journal of Pathology, 2001
- A novel presenilin 1 mutation (Leu166Arg) associated with early-onset Alzheimer disease.Archives of Neurology, 2000